Association Between Serum Klotho and Chronic Obstructive Pulmonary Disease in US Middle-Aged and Older Individuals: A Cross-Sectional Study from NHANES 2013–2016
Yushan Shi,Zhangmeng Xu,Shuangshuang Pu,Kanghong Xu,Yanan Wang,Chunlai Zhang
DOI: https://doi.org/10.2147/copd.s451859
2024-02-26
International Journal of COPD
Abstract:Yushan Shi, 1, &ast Zhangmeng Xu, 2, &ast Shuangshuang Pu, 1 Kanghong Xu, 1 Yanan Wang, 1 Chunlai Zhang 1 1 Department of Laboratory Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 25000, People's Republic of China; 2 School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chunlai Zhang, Department of Laboratory Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jingshi Road, Lixia, Jinan, Shandong, 25000, People's Republic of China, Tel +86+15863139900, Email Purpose: This study sought to examine the potential association between serum Klotho levels and the prevalence of COPD in the United States. Patients and Methods: This study was a cross-sectional analysis involving 4361 adults aged 40– 79 years participating in the US National Health and Nutrition Examination Survey (NHANES) conducted between 2013 and 2016. Our investigation utilized multivariate logistic regression and restricted cubic spline (RCS) regression to explore the potential correlation between serum Klotho concentrations and the prevalence of COPD. Additionally, we conducted stratified and interaction analyses to evaluate the consistency and potential modifiers of this relationship. Results: In this study encompassing 4631 patients (with an average age of 57.6 years, 47.5% of whom were male), 445 individuals (10.2%) were identified as having COPD. In the fully adjusted model, ln-transformed serum Klotho was negatively associated with COPD (OR = 0.71; 95% CI: 0.51– 0.99; p = 0.043). Meanwhile, compared with quartile 1, serum Klotho levels in quartiles 2– 4 yielded odds ratios (ORs) (95% CI) for COPD were 0.84 (0.63~1.11), 0.76 (0.56~1.02), 0.84 (0.62~1.13), respectively. A negative relationship was observed between the ln-transformed serum Klotho and occurrence of COPD (nonlinear: p = 0.140). the association between ln-transformed serum Klotho and COPD were stable in stratified analyses. Conclusion: Serum Klotho was negatively associated with the incidence of COPD, when ln-transformed Klotho concentration increased by 1 unit, the risk of COPD was 29% lower. Keywords: α-Klotho (Klotho), chronic obstructive pulmonary disease, cross-sectional study, National Health and Nutrition Survey, NHANES Chronic obstructive pulmonary disease (COPD) is a multifaceted and intricate lung condition marked by persistent respiratory symptoms and obstruction in airflow. 1 Two main subtypes of COPD are chronic bronchitis and emphysema. 2 In the United States (US), COPD stands as a leading cause of disability and ranks third in terms of mortality, imposing a substantial burden on clinical and healthcare resources. 3 Globally, the prevalence of COPD was 10.1% in people aged 40 years or older. 4 Numerous studies have explored the mechanistic underpinnings of COPD, highlighting the significant roles of protease/antiprotease imbalance, inflammation, oxidative stress, and aging in its pathogenesis. 5–8 COPD is often regarded as a disease characterized by accelerated aging, with several aging pathways implicated in its development. 9–11 COPD poses a particular challenge for middle-aged and older populations because age-related factors may influence its course and severity. Alpha-Klotho (Klotho) was first identified in 1997 by Kuro- o et al describing a gene mutation in mice involved in aging and arteriosclerosis. 12 Klotho serves as both a paracrine and endocrine hormonal factor, contributing to various biological functions within the circulatory system. These functions encompass the regulation of inflammation, antioxidative processes, and the prevention of senescence. 13,14 Conversely, Klotho potentially participates in various physiological functions associated with aging and exerts an inhibitory influence on aging processes in several human organs. Insufficient Klotho levels may lead to diverse age-related diseases, such as diabetes, atherosclerosis, endothelial dysfunction, reduced bone mineral density, and depression. 15–19 Studies have shown that the expression of Klotho in the airways of COPD patients is reduced. 20 Furthermore, Klotho functions as a co-receptor for the circulating hormone fibroblast growth factor 23 (FGF23), potentially playing a role in the development of airway inflammation. 21 Furthermore, mice lacking Klotho exhibit an aging phenotype with widened alveolar spaces, consistent wi -Abstract Truncated-
respiratory system